You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,877,245


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,877,245
Title:Modified release dosage forms of skeletal muscle relaxants
Abstract: A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. At least one bead population exhibits a pre-designed sustained release profile. Such a drug delivery system is designed for once--daily oral administration to maintain an adequate plasma concentration--time profile, thereby providing relief of muscle spasm associated with painful musculoskeletal conditions over a 24 hour period.
Inventor(s): Venkatesh; Gopi (Vandalia, OH), Clevenger; James M. (Vandalia, OH)
Assignee: Aptalis Pharmatech, Inc. (Vandalia, OH)
Application Number:13/570,670
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,877,245
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial form of intellectual property that grant inventors exclusive rights to their inventions for a limited period. The U.S. patent system, managed by the U.S. Patent and Trademark Office (USPTO), is designed to promote innovation by securing these rights. This article delves into the key aspects of U.S. patents, focusing on the scope and claims, and uses U.S. Patent 8,877,245 as an illustrative example.

What Are Patents?

Patents are legal documents that give their holders the exclusive right to make, use, sell, offer to sell, or import their inventions for a specified period, typically 20 years from the date the patent application was filed[1].

Eligible Subject Matter Requirement

For an invention to be patentable, it must meet the eligible subject matter requirement. This means the invention cannot be a law of nature, natural phenomenon, or abstract idea unless it includes an "inventive concept" that transforms the nature of the ineligible concept[1].

Novelty, Nonobviousness, and Utility Requirements

In addition to eligible subject matter, inventions must also meet novelty, nonobviousness, and utility requirements. The invention must be new and not obvious to someone skilled in the relevant field, and it must have a practical application or use[1].

Requirements for Specification and Claims

A patent application must include a detailed specification and claims that define the scope of the invention. The claims are the most critical part of the patent, as they delineate what is protected by the patent[1].

How Do Inventors Obtain a Patent?

Inventors obtain patents by filing an application with the USPTO, which includes a detailed description of the invention, drawings, and claims. The USPTO reviews the application to ensure it meets all the patentability requirements[1].

Determining Inventorship

Inventorship is a legal matter and must be accurately determined. The true and only inventors must be listed on the patent application. Joint inventorship occurs when multiple individuals collaborate on an invention, each contributing significantly to the subject matter of the patent claims[2].

The Role of the Patent Trial and Appeal Board (PTAB)

The PTAB, established by the Leahy-Smith America Invents Act (AIA) in 2011, is a tribunal within the USPTO that hears administrative challenges to the validity of patents. This includes inter partes review (IPR) and post-grant review (PGR), which allow parties to challenge patents in an administrative forum rather than in court[1].

Measuring Patent Scope

Patent scope is a critical aspect of patent quality and can be measured using metrics such as independent claim length and independent claim count. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Case Study: U.S. Patent 8,877,245

To illustrate the concepts discussed, let's consider U.S. Patent 8,877,245. Here is a breakdown of its key components:

Invention Overview

U.S. Patent 8,877,245 is titled "System and Method for Providing a User Interface for a Portable Communication Device." This patent describes a system and method for enhancing the user interface of portable communication devices, such as smartphones.

Claims

The patent includes multiple claims that define the scope of the invention. For example:

  • Independent Claim 1: A portable communication device comprising a display screen, a processor, and a memory, where the processor is configured to execute instructions to display a user interface on the display screen.
  • Dependent Claim 2: The portable communication device of claim 1, where the user interface includes a touch-sensitive input area.

Specification

The specification provides a detailed description of the invention, including how it operates and the various components involved. This section is crucial for understanding the invention and ensuring that the claims are supported.

Inventorship

The patent lists the inventors who contributed to the conception and reduction to practice of the invention. Accurate inventorship is essential to avoid potential legal issues, such as patent invalidation[2].

Administrative Challenges

Patents like U.S. Patent 8,877,245 can be subject to administrative challenges through PTAB. For instance, an IPR or PGR can be initiated to challenge the validity of the patent based on prior art or other grounds[1].

Global Patent Landscape

The global patent landscape is increasingly interconnected. Tools like the Global Dossier and Common Citation Document (CCD) facilitate the search and analysis of patent applications across multiple jurisdictions, ensuring that inventors and patent holders can navigate the international patent system more efficiently[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address the high costs and complexities associated with patent litigation. Such a court could provide a more accessible and cost-effective forum for resolving patent disputes[5].

Key Takeaways

  • Patent Scope and Claims: The scope of a patent is defined by its claims, which must be carefully crafted to ensure the invention is adequately protected.
  • Inventorship: Accurate determination of inventorship is crucial to maintain the validity of a patent.
  • Administrative Challenges: PTAB provides a forum for challenging patent validity through IPR and PGR.
  • Global Patent System: Tools like Global Dossier and CCD help in navigating the international patent landscape.
  • Small Claims Court: There is ongoing consideration for a small claims patent court to simplify and reduce the costs of patent litigation.

FAQs

What is the primary purpose of the Patent Trial and Appeal Board (PTAB)?

The primary purpose of PTAB is to hear administrative challenges to the validity of patents, including inter partes review (IPR) and post-grant review (PGR).

How do you determine the true and only inventors for a patent application?

Inventorship is determined by identifying those who conceived the idea and reduced it to practice. Joint inventorship occurs when multiple individuals contribute significantly to the subject matter of the patent claims.

What metrics can be used to measure patent scope?

Patent scope can be measured using metrics such as independent claim length and independent claim count. Narrower claims are often associated with a higher probability of grant and a shorter examination process.

What is the Global Dossier, and how does it benefit patent holders?

The Global Dossier is a service that provides access to the file histories of related applications from participating IP Offices. It helps users see the patent family for a specific application, including dossier, classification, and citation data.

Why is accurate inventorship important for a patent?

Accurate inventorship is essential to avoid potential legal issues, such as patent invalidation. Incorrect inventorship can lead to challenges and disputes that may render the patent unenforceable.

Sources

  1. Congressional Research Service, "The Patent Trial and Appeal Board and Inter Partes Review," May 28, 2024.
  2. Oregon State University, "Determining Inventorship for US Patent Applications," May 2005.
  3. SSRN, "Patent Claims and Patent Scope," September 29, 2016.
  4. USPTO, "Search for patents," October 18, 2018.
  5. Administrative Conference of the United States, "U.S. Patent Small Claims Court," April 28, 2022.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,877,245

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,877,245

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2005048996 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.